Evidence map›Paper›PMID 30717447›Full record

ArticleCells2019

Host Vesicle Fusion Protein VAPB Contributes to the Nuclear Egress Stage of Herpes Simplex Virus Type-1 (HSV-1) Replication.

Natalia Saiz-Ros, Rafal Czapiewski, Ilaria Epifano, Andrew Stevenson, Selene K Swanson, Charles R Dixon, Dario B Zamora, Marion McElwee, Swetha Vijayakrishnan, Christine A Richardson and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Sequestosome 1 Is Part of the Interaction Network of VAPB.International journal of molecular sciences · 2021
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Natalia Saiz-RosThe Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK. nsaizros@gmail.com.
Rafal CzapiewskiThe Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK. Rafal.Czapiewski@ed.ac.uk.ORCID 0000-0003-0211-8435
Ilaria EpifanoMRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK. I.Epifano.1@research.gla.ac.uk.ORCID 0000-0002-2056-0510
Andrew StevensonMRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK. Andrew.Stevenson.2@glasgow.ac.uk.
Selene K SwansonStowers Institute for Medical Research, Kansas City, MO 64110, USA. ses@stowers.org.
Charles R DixonThe Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK. s1581423@sms.ed.ac.uk.ORCID 0000-0001-9565-9710
Dario B ZamoraThe Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK. Dario.Barreiros@ed.ac.uk.
Marion McElweeMRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK. Marion.McElwee@gla.ac.uk.
Swetha VijayakrishnanMRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK. Swetha.Vijayakrishnan@glasgow.ac.uk.
Christine A RichardsonSchool of Biological and Biomedical Sciences, Durham University, Durham DH1 3LE, UK. a.c.richardson@durham.ac.uk.ORCID 0000-0003-2622-2261
Li DongMRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK. l.dong.1@research.gla.ac.uk.
David A KellyThe Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK. David.Kelly@ed.ac.uk.ORCID 0000-0002-3021-8495
Lior PytowskiThe Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK. lior.pytowski@gmail.com.ORCID 0000-0002-8530-5123
Martin W GoldbergSchool of Biological and Biomedical Sciences, Durham University, Durham DH1 3LE, UK. m.w.goldberg@durham.ac.uk.
Laurence FlorensStowers Institute for Medical Research, Kansas City, MO 64110, USA. LAF@stowers.org.ORCID 0000-0002-9310-6650
Sheila V GrahamMRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK. e.schirmer@ed.ac.uk.
Eric C SchirmerThe Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK. Sheila.Graham@glasgow.ac.uk.ORCID 0000-0003-2635-1338
Wellcome Centre for Cell Biology · GBMRC University of Glasgow Centre for Virus Research · GBDurham University · GBStowers Institute for Medical Research · US

Funding

Medical Research Council MC_UU_12014/3Medical Research Council MC_UU_12014/7Wellcome Trust 092076Wellcome Trust 095209Wellcome Trust 109089
6 · The paper itself

Abstract

The primary envelopment/de-envelopment of Herpes viruses during nuclear exit is poorly understood. In Herpes simplex virus type-1 (HSV-1), proteins pUL31 and pUL34 are critical, while pUS3 and some others contribute; however, efficient membrane fusion may require additional host proteins. We postulated that vesicle fusion proteins present in the nuclear envelope might facilitate primary envelopment and/or de-envelopment fusion with the outer nuclear membrane. Indeed, a subpopulation of vesicle-associated membrane protein-associated protein B (VAPB), a known vesicle trafficking protein, was present in the nuclear membrane co-locating with pUL34. VAPB knockdown significantly reduced both cell-associated and supernatant virus titers. Moreover, VAPB depletion reduced cytoplasmic accumulation of virus particles and increased levels of nuclear encapsidated viral DNA. These results suggest that VAPB is an important player in the exit of primary enveloped HSV-1 virions from the nucleus. Importantly, VAPB knockdown did not alter pUL34, calnexin or GM-130 localization during infection, arguing against an indirect effect of VAPB on cellular vesicles and trafficking. Immunogold-labelling electron microscopy confirmed VAPB presence in nuclear membranes and moreover associated with primary enveloped HSV-1 particles. These data suggest that VAPB could be a cellular component of a complex that facilitates UL31/UL34/US3-mediated HSV-1 nuclear egress.

Indexed as

Membrane FusionAnimalsCell NucleusChlorocebus aethiopsHeLa CellsHerpes SimplexHerpesvirus 1, HumanHumansIntracellular MembranesMicrosomesNuclear EnvelopeVero CellsVesicular Transport ProteinsViral ProteinsVirionVirus ReleaseVAPB protein, humanVesicular Transport ProteinsViral Proteinsherpes simplex virus-1 (HSV-1)nuclear egressnuclear envelopenuclear membrane proteinVAPBvesicle fusion protein (VFP)

Identifiers

PMID30717447
PMCPMC6406291
OpenAlexW2912752754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.